210 related articles for article (PubMed ID: 15753367)
21. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice.
Kanatani A; Mashiko S; Murai N; Sugimoto N; Ito J; Fukuroda T; Fukami T; Morin N; MacNeil DJ; Van der Ploeg LH; Saga Y; Nishimura S; Ihara M
Endocrinology; 2000 Mar; 141(3):1011-6. PubMed ID: 10698177
[TBL] [Abstract][Full Text] [Related]
22. Glial-derived neurotrophic factor modulates enteric neuronal survival and proliferation through neuropeptide Y.
Anitha M; Chandrasekharan B; Salgado JR; Grouzmann E; Mwangi S; Sitaraman SV; Srinivasan S
Gastroenterology; 2006 Oct; 131(4):1164-78. PubMed ID: 17030186
[TBL] [Abstract][Full Text] [Related]
23. Involvement of neuropeptide Y and its Y1 and Y5 receptors in maintaining self-renewal and proliferation of human embryonic stem cells.
Son MY; Kim MJ; Yu K; Koo DB; Cho YS
J Cell Mol Med; 2011 Jan; 15(1):152-65. PubMed ID: 19874423
[TBL] [Abstract][Full Text] [Related]
24. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
Henry M; Ghibaudi L; Gao J; Hwa JJ
Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
[TBL] [Abstract][Full Text] [Related]
25. NPY and NPY receptors in vascular remodeling.
Abe K; Tilan JU; Zukowska Z
Curr Top Med Chem; 2007; 7(17):1704-9. PubMed ID: 17979779
[TBL] [Abstract][Full Text] [Related]
26. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
[TBL] [Abstract][Full Text] [Related]
27. Emerging novel roles of neuropeptide Y in the retina: from neuromodulation to neuroprotection.
Santos-Carvalho A; Álvaro AR; Martins J; Ambrósio AF; Cavadas C
Prog Neurobiol; 2014 Jan; 112():70-9. PubMed ID: 24184719
[TBL] [Abstract][Full Text] [Related]
28. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
[TBL] [Abstract][Full Text] [Related]
29. Of mice and men: neuropeptide Y and its receptors are associated with atherosclerotic lesion burden and vulnerability.
Li L; Najafi AH; Kitlinska JB; Neville R; Laredo J; Epstein SE; Burnett MS; Zukowska Z
J Cardiovasc Transl Res; 2011 Jun; 4(3):351-62. PubMed ID: 21468772
[TBL] [Abstract][Full Text] [Related]
30. Neuropeptide Y: multiple receptors and multiple roles in cardiovascular diseases.
Pons J; Lee EW; Li L; Kitlinska J
Curr Opin Investig Drugs; 2004 Sep; 5(9):957-62. PubMed ID: 15503651
[TBL] [Abstract][Full Text] [Related]
31. Effects of differentiation on neuropeptide-Y receptors and responses in rat pheochromocytoma cells.
DiMaggio DA; Farah JM; Westfall TC
Endocrinology; 1994 Feb; 134(2):719-27. PubMed ID: 8299567
[TBL] [Abstract][Full Text] [Related]
32. Neuropeptide Y and the retinal pigment epithelium: receptor subtypes, signaling, and bioelectrical responses.
Ammar DA; Hughes BA; Thompson DA
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1870-8. PubMed ID: 9727410
[TBL] [Abstract][Full Text] [Related]
33. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
[TBL] [Abstract][Full Text] [Related]
34. Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies.
Tessel RE; Miller DW; Misse GA; Dong X; Doughty MB
J Pharmacol Exp Ther; 1993 Apr; 265(1):172-7. PubMed ID: 8474004
[TBL] [Abstract][Full Text] [Related]
35. Neuropeptide Y induced feeding in the rat is mediated by a novel receptor.
O'Shea D; Morgan DG; Meeran K; Edwards CM; Turton MD; Choi SJ; Heath MM; Gunn I; Taylor GM; Howard JK; Bloom CI; Small CJ; Haddo O; Ma JJ; Callinan W; Smith DM; Ghatei MA; Bloom SR
Endocrinology; 1997 Jan; 138(1):196-202. PubMed ID: 8977404
[TBL] [Abstract][Full Text] [Related]
36. Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell line.
Medeiros PJ; Al-Khazraji BK; Novielli NM; Postovit LM; Chambers AF; Jackson DN
Int J Cancer; 2012 Jul; 131(2):276-86. PubMed ID: 21823118
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects.
Tilan JU; Lu C; Galli S; Izycka-Swieszewska E; Earnest JP; Shabbir A; Everhart LM; Wang S; Martin S; Horton M; Mahajan A; Christian D; O'Neill A; Wang H; Zhuang T; Czarnecka M; Johnson MD; Toretsky JA; Kitlinska J
Oncotarget; 2013 Dec; 4(12):2487-501. PubMed ID: 24318733
[TBL] [Abstract][Full Text] [Related]
38. Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?
Zukowska Z; Pons J; Lee EW; Li L
Can J Physiol Pharmacol; 2003 Feb; 81(2):89-94. PubMed ID: 12710520
[TBL] [Abstract][Full Text] [Related]
39. Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells.
Ruscica M; Dozio E; Boghossian S; Bovo G; Martos Riaño V; Motta M; Magni P
Endocrinology; 2006 Mar; 147(3):1466-73. PubMed ID: 16339211
[TBL] [Abstract][Full Text] [Related]
40. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
Malmström RE
Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
